Fennec Pharmaceuticals Inc.
FENC
$5.97
-$0.04-0.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.63M | 40.32M | 43.05M | 51.18M | 13.27M |
| Total Receivables | 12.88M | 12.91M | 12.31M | 10.27M | 8.81M |
| Inventory | 1.06M | 1.13M | 2.14M | 2.06M | 2.16M |
| Prepaid Expenses | 3.08M | 3.07M | 4.38M | 4.49M | 2.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 466.00K | 546.00K | 283.00K | 161.00K | 44.00K |
| Total Current Assets | 44.12M | 57.97M | 62.17M | 68.17M | 26.86M |
|
|
|||||
| Total Current Assets | 44.12M | 57.97M | 62.17M | 68.17M | 26.86M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 822.00K | 956.00K | 989.00K | 1.02M | 6.00K |
| Total Assets | 44.95M | 58.92M | 63.16M | 69.19M | 26.86M |
|
|
|||||
| Total Accounts Payable | 3.24M | 3.87M | 4.45M | 5.20M | 3.78M |
| Total Accrued Expenses | 3.43M | 3.31M | 3.04M | 4.36M | 3.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.00K | 7.00K | 12.00K | 17.00K | 21.00K |
| Total Finance Division Other Current Liabilities | 248.00K | 248.00K | 252.00K | 252.00K | -- |
| Total Other Current Liabilities | 248.00K | 248.00K | 252.00K | 252.00K | -- |
| Total Current Liabilities | 6.92M | 7.44M | 7.75M | 9.84M | 7.55M |
|
|
|||||
| Total Current Liabilities | 6.92M | 7.44M | 7.75M | 9.84M | 7.55M |
| Long-Term Debt | 19.34M | 32.10M | 31.78M | 31.35M | 30.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.56M | 24.56M | 24.99M | 24.99M | 2.00K |
| Total Liabilities | 50.82M | 64.09M | 64.52M | 66.18M | 38.49M |
|
|
|||||
| Common Stock & APIC | 212.57M | 211.28M | 209.36M | 208.18M | 206.38M |
| Retained Earnings | -219.68M | -217.70M | -211.96M | -206.41M | -219.25M |
| Treasury Stock & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Total Common Equity | -5.87M | -5.17M | -1.36M | 3.01M | -11.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.87M | -5.17M | -1.36M | 3.01M | -11.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.87M | -5.17M | -1.36M | 3.01M | -11.62M |
|
|
|||||